Q-Line Biotech Limited - Company Profile

It is a healthcare public limited company based in Lucknow, Uttar Pradesh, India, established in 2010.
2010 Lucknow, Uttar Pradesh, India Active
Last Updated:
Access Report
About Q-Line Biotech Limited

Q-Line Biotech Limited, a active public limited company, was established on 10 November 2010 in Lucknow, Uttar Pradesh, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74120UP2010PLC042528. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹16.27 Cr.

Formerly known as Poct Services Private Limited, Sperogenx Lifesciences Private Limited. It upholds a compliant status. Employing 219 professional, Its leadership includes Ayush Garg (Director), Kuldeep Chowdhry (Whole-Time Director), Pravir Kumar (Director). Past directors included Manisha Yadav, Ayush Garg, Kuldeep Chowdhry. It holds ₹239.56 Cr open charges and ₹18.72 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120UP2010PLC042528

  • Registration Number

    042528

  • Incorporation Date

    10 November 2010

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹16.27 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 16.27 Cr
  • Company Age 15 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 239.56 Cr
  • Satisfied Charges ₹ 18.72 Cr
  • Revenue Growth **** -33.70%
  • Profit Growth **** -49.13%
  • Ebitda **** -44.73%
  • Net Worth 24.20%
  • Total Assets **** 20.22%
Company report

Q-Line Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Q-Line Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Q-Line Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Ayush Garg Director 01 Jul 2023 Current
Kuldeep Chowdhry Whole-Time Director 12 Jan 2015 Current
Pravir Kumar Director 08 May 2025 Current
Yethadka Subraya Prabhakara Whole-Time Director 08 May 2025 Current
Saurabh Garg Managing Director 10 Nov 2010 Current
Meenal Gupta Cfo 25 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 28 Sep 2015 Past
Pramod Abcsdd Director 31 Jul 2025 Past
Pramod Abcsdd Additional Director 28 Sep 2015 Past
Pramod Abcsdd Additional Director 28 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Q-Line Biotech.

Q-Line Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.7% decrease. The company also saw a substantial fall in profitability, with a 49.13% decrease in profit. The company's net worth Soared by an impressive increase of 24.2%.

Q-Line Biotech revenue growth over time
Q-Line Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -33.70%
*******
*******
*******
*******
Revenue from Operations
*******
 -34.23%
*******
*******
*******
*******
Total Assets
*******
 20.22%
*******
*******
*******
*******
Profit or Loss
*******
 -49.13%
*******
*******
*******
*******
Net Worth
*******
 24.20%
*******
*******
*******
*******
EBITDA
*******
 -44.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Q-Line Biotech?

In 2023, Q-Line Biotech had a promoter holding of 95.24% and a public holding of 4.76%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,395,585,650.00

Satisfied Charges

₹187,167,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 166.56 Cr
  • Others : 73.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Nov 2025 Others ₹30.00 Cr Open
16 May 2024 Others ₹2.50 M Open
21 Mar 2024 Others ₹6.75 Cr Open
20 Mar 2024 Others ₹36.00 Cr Open
11 Dec 2023 Hdfc Bank Limited ₹1.61 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Q-Line Biotech?

Q-Line Biotech has a workforce of 219 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Q-Line Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Q-Line Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Q-Line Biotech
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101193879 was registered on 27 Nov 2025. was completed.

  • Charges

    A charge with Others of Rs. 36.00 Cr registered on 20 Mar 2024 with Charge ID 100907646 was modified on 16 Oct 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 155.77 Cr registered on 13 Mar 2019 with Charge ID 100255677 was modified on 29 Sep 2025. was documented.

  • Director Appointment

    The activity Meenal Gupta was appointed as a Cfo was appointed as a Cfo on 20 Aug 2025 & has been associated with this company since 5 months 24 days . was completed.

  • Director Appointment

    Progress on Jai Prakash Singh was appointed as a Director was appointed as a Director on 01 Aug 2025 & has been associated with this company since 6 months 13 days . was documented.

  • Director Appointment

    The activity Meenal Gupta was appointed as a CFO was appointed as a CFO on 25 Jul 2025 & has been associated with this company since 6 months 20 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Q-Line Biotech Limited?

The CIN of Q-Line Biotech Limited is U74120UP2010PLC042528.

Where is Q-Line Biotech Limited headquartered?

Q-Line Biotech Limited is headquartered at 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012.

When was Q-Line Biotech Limited incorporated?

Q-Line Biotech Limited was incorporated on 10 November 2010.

Who are the current directors of Q-Line Biotech Limited?

The current directors of Q-Line Biotech Limited are

What is the primary industry of Q-Line Biotech Limited?

The primary industry of Q-Line Biotech Limited is Trade.

Is Q-Line Biotech Limited a listed company?

Q-Line Biotech Limited is unlisted.

What is the capital structure of Q-Line Biotech Limited?

The authorized capital of Q-Line Biotech Limited is ₹25.00 Cr, and the paid-up capital is ₹16.27 Cr.

What is the compliance status of Q-Line Biotech Limited?

The compliance status of Q-Line Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available